Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Halozyme Therapeutics

Halozyme Therapeutics reported $1.49B in Loan Capital for its fiscal quarter ending in March of 2023.

Loan Capital Change
Alnylam Pharmaceuticals ALNY:US USD 1.02B 945K
Amgen AMGN:US USD 60.76B 23.41B
Baxter International BAX:US USD 15.28B 46M
Eli Lilly LLY:US USD 18.88B 4.14B
Esperion Therapeutics ESPR:US USD 260.32M 417K
Halozyme Therapeutics HALO:US USD 1.49B 1.61M
Intercept Pharmaceuticals ICPT:US USD 223.35M 248K
Ionis Pharmaceuticals IONS:US USD 1.18B 1.66M
MannKind MNKD:US USD 356.73M 11.27M
Peregrine Pharmaceuticals PPHM:US USD 142.06M 129K
United Therapeutics UTHR:US USD 800M 0